Moderna Capitalizes on Stock Jump With $2 Billion Note Offering

Moderna Inc. plans to raise $2 billion from selling notes that can be exchanged for shares, which it will use to invest in its cancer vaccine business and to repay debt.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.